Crossmark

Application of Plackett–Burman and Box–Behnken designs to develop a sensitive and robust HPLC method for quantifying hypolipidemic drugs, rosuvastatin and bempedoic acid in tablets

Crossref DOI link: https://doi.org/10.1186/s43094-025-00814-6

Published Online: 2025-05-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aggarapu, Susmitha https://orcid.org/0000-0001-9228-1126
Galla, Rajitha https://orcid.org/0000-0001-6178-0715
Shaik, Neha Jabeen https://orcid.org/0009-0001-4449-4212
Dasari, Sai Jyothi https://orcid.org/0009-0006-3550-6767
License Information

Text and Data Mining valid from 2025-05-26

Version of Record valid from 2025-05-26
More Information

Article History

Received: 17 September 2024

Accepted: 24 April 2025

First Online: 26 May 2025

Declarations

:

: Not applicable.

: Not applicable. This article does not contain any studies with human participants performed by any of the authors.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below